UB Paderborn / Katalog / Suche / in CDI

Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier

Journal of Virology, 2007-12, Vol.81 (24), p.13845-13851

2007

Link zum Volltext

Verfügbarkeit prüfen

Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors

Journal of Virology, 2008-11, Vol.82 (21), p.10366-10374

2008

Link zum Volltext

Verfügbarkeit prüfen

Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”

The Journal of biological chemistry, 2008-10, Vol.283 (44), p.29904-29911

2008

Link zum Volltext

Verfügbarkeit prüfen

Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages

Virology (New York, N.Y.), 2006-12, Vol.356 (1), p.79-94

2006

Link zum Volltext

Verfügbarkeit prüfen

A Novel Nonnucleoside Inhibitor Specifically Targets Cytomegalovirus DNA Maturation via the UL89 and UL56 Gene Products

Journal of Virology, 2001-10, Vol.75 (19), p.9077-9086

2001

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60

Nature (London), 1992-11, Vol.360 (6402), p.358-361

1992

Link zum Volltext

Verfügbarkeit prüfen

Development of robust antiviral assays for profiling compounds against a panel of positive-strand RNA viruses using ATP/luminescence readout

Journal of virological methods, 2008-07, Vol.151 (1), p.121-125

2008

Link zum Volltext

Verfügbarkeit prüfen

MAPPIT (MAmmalian Protein–Protein Interaction Trap) as a tool to study HIV reverse transcriptase dimerization in intact human cells

Journal of virological methods, 2008-10, Vol.153 (1), p.7-15

2008

Link zum Volltext

Verfügbarkeit prüfen

The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs

Antiviral research, 2005, Vol.65 (1), p.35-43

2005

Link zum Volltext

Verfügbarkeit prüfen

Processing and routage of HIV glycoproteins by furin to the cell surface

Virus research, 1999-03, Vol.60 (1), p.55-65

1999

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo

Antiviral research, 2001-03, Vol.49 (3), p.179-189

2001

Link zum Volltext

Verfügbarkeit prüfen

Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors

Bioorganic & medicinal chemistry letters, 2012-08, Vol.22 (15), p.4998-5002

2012

Link zum Volltext

Verfügbarkeit prüfen

Antiviral therapies

Journal of clinical virology, 2004-04, Vol.30, p.S22-S24

Hallenberger, Sabine

2004

Link zum Volltext

Verfügbarkeit prüfen

Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action

Journal of antimicrobial chemotherapy, 2001-12, Vol.48 (6), p.757-767

2001

Link zum Volltext

Verfügbarkeit prüfen

Anti-HIV State but Not Apoptosis Depends on IFN Signature in CD4+ T Cells

The Journal of immunology (1950), 2006-11, Vol.177 (9), p.6227-6237

2006

Link zum Volltext

Verfügbarkeit prüfen

Antivirals against DNA viruses (hepatitis B and the herpes viruses)

Current opinion in pharmacology, 2004-10, Vol.4 (5), p.453-464

2004

Link zum Volltext

Verfügbarkeit prüfen

Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against âNucleotide-competing Reverse Transcriptase Inhibitorsâ

The Journal of biological chemistry, 2008-10, Vol.283 (44), p.29904

2008

Link zum Volltext

Verfügbarkeit prüfen

Development of ATP/Luminescence Assays For Profiling Compounds Against A Panel of Positive-Strand RNA Viruses

Antiviral research, 2007-06, Vol.74 (3), p.A58-A58

2007

Link zum Volltext

Verfügbarkeit prüfen

Anti-HIV State but Not Apoptosis Depends on IFN Signature in CD4 super(+) T Cells

Journal of Immunology, 2006-11, Vol.177 (9), p.6227-6237

2006

Link zum Volltext

Verfügbarkeit prüfen

Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1κ monoclonal antibody, in HIV-1 infected cells

Journal of virological methods, 2007, Vol.139 (1), p.17-23

2007

Link zum Volltext

Verfügbarkeit prüfen

Binding kinetics, uptake and intracellular accumulation of F105, an anti-gpl20 human IgG1κ monoclonal antibody, in HIV-1 infected cells

Journal of virological methods, 2007, Vol.139 (1), p.17-23

2007

Link zum Volltext

Verfügbarkeit prüfen

Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells

Journal of virological methods, 2007-01, Vol.139 (1), p.17-23

2007

Link zum Volltext

Verfügbarkeit prüfen

Secretion of a Truncated Form of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein

Virology (New York, N.Y.), 1993-03, Vol.193 (1), p.510-514

1993

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier

Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors

Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”

Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages

A Novel Nonnucleoside Inhibitor Specifically Targets Cytomegalovirus DNA Maturation via the UL89 and UL56 Gene Products

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60

Development of robust antiviral assays for profiling compounds against a panel of positive-strand RNA viruses using ATP/luminescence readout

MAPPIT (MAmmalian Protein–Protein Interaction Trap) as a tool to study HIV reverse transcriptase dimerization in intact human cells

The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs

Processing and routage of HIV glycoproteins by furin to the cell surface

Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo

Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors

Antiviral therapies

Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action

Anti-HIV State but Not Apoptosis Depends on IFN Signature in CD4+ T Cells

Antivirals against DNA viruses (hepatitis B and the herpes viruses)

Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against âNucleotide-competing Reverse Transcriptase Inhibitorsâ

Development of ATP/Luminescence Assays For Profiling Compounds Against A Panel of Positive-Strand RNA Viruses

Anti-HIV State but Not Apoptosis Depends on IFN Signature in CD4 super(+) T Cells

Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1κ monoclonal antibody, in HIV-1 infected cells

Binding kinetics, uptake and intracellular accumulation of F105, an anti-gpl20 human IgG1κ monoclonal antibody, in HIV-1 infected cells

Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells

Secretion of a Truncated Form of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein

Suchergebnisse filtern